Cargando…

Rosmarinic acid prevents post-operative abdominal adhesions in a rat model

This study aims to determine the effects of rosmarinic acid which involved the mechanisms to decrease the postoperative peritoneal adhesion formation in rats. Various incisions and removing a 1 × 1 cm piece of peritoneum was used to induce the peritoneal adhesions. Experimental groups were as follow...

Descripción completa

Detalles Bibliográficos
Autores principales: Kakanezhadi, Ali, Rezaei, Mehrdad, Raisi, Abbas, Dezfoulian, Omid, Davoodi, Farshid, Ahmadvand, Hassan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9633689/
https://www.ncbi.nlm.nih.gov/pubmed/36329196
http://dx.doi.org/10.1038/s41598-022-22000-x
_version_ 1784824293246369792
author Kakanezhadi, Ali
Rezaei, Mehrdad
Raisi, Abbas
Dezfoulian, Omid
Davoodi, Farshid
Ahmadvand, Hassan
author_facet Kakanezhadi, Ali
Rezaei, Mehrdad
Raisi, Abbas
Dezfoulian, Omid
Davoodi, Farshid
Ahmadvand, Hassan
author_sort Kakanezhadi, Ali
collection PubMed
description This study aims to determine the effects of rosmarinic acid which involved the mechanisms to decrease the postoperative peritoneal adhesion formation in rats. Various incisions and removing a 1 × 1 cm piece of peritoneum was used to induce the peritoneal adhesions. Experimental groups were as follows: 1—Sham group. 2—Control group: Peritoneal adhesions were induced and no treatments were performed. 3—Treatment groups: Following inducing peritoneal adhesions, animals received rosmarinic acid with 50 and 70 mg/kg dosage, respectively. Macroscopic examination of adhesions indicated that adhesion bands were reduced in both treatment groups compared to the control group. Moreover, the adhesion score was decreased in both treatment groups on day 14. Inflammation and fibroblast proliferation were both reduced in the treatment groups on day 14. TGF-β1, TNF-α, and VEGF were all evaluated by western blot and immunohistochemistry on days 3 and 14. Treatment groups reduced inflammatory cytokines on days 3 and 14. The treatment group with a 70 mg/kg dosage decreased TGF-β1 and TNF-α levels more than the other treatment group. The administration of rosmarinic acid significantly reduced MDA and increased CAT levels. In conclusion, the rosmarinic acid was effective to reduce the adhesion bands, inflammatory cytokines, angiogenesis, and oxidative stress.
format Online
Article
Text
id pubmed-9633689
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-96336892022-11-05 Rosmarinic acid prevents post-operative abdominal adhesions in a rat model Kakanezhadi, Ali Rezaei, Mehrdad Raisi, Abbas Dezfoulian, Omid Davoodi, Farshid Ahmadvand, Hassan Sci Rep Article This study aims to determine the effects of rosmarinic acid which involved the mechanisms to decrease the postoperative peritoneal adhesion formation in rats. Various incisions and removing a 1 × 1 cm piece of peritoneum was used to induce the peritoneal adhesions. Experimental groups were as follows: 1—Sham group. 2—Control group: Peritoneal adhesions were induced and no treatments were performed. 3—Treatment groups: Following inducing peritoneal adhesions, animals received rosmarinic acid with 50 and 70 mg/kg dosage, respectively. Macroscopic examination of adhesions indicated that adhesion bands were reduced in both treatment groups compared to the control group. Moreover, the adhesion score was decreased in both treatment groups on day 14. Inflammation and fibroblast proliferation were both reduced in the treatment groups on day 14. TGF-β1, TNF-α, and VEGF were all evaluated by western blot and immunohistochemistry on days 3 and 14. Treatment groups reduced inflammatory cytokines on days 3 and 14. The treatment group with a 70 mg/kg dosage decreased TGF-β1 and TNF-α levels more than the other treatment group. The administration of rosmarinic acid significantly reduced MDA and increased CAT levels. In conclusion, the rosmarinic acid was effective to reduce the adhesion bands, inflammatory cytokines, angiogenesis, and oxidative stress. Nature Publishing Group UK 2022-11-03 /pmc/articles/PMC9633689/ /pubmed/36329196 http://dx.doi.org/10.1038/s41598-022-22000-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Kakanezhadi, Ali
Rezaei, Mehrdad
Raisi, Abbas
Dezfoulian, Omid
Davoodi, Farshid
Ahmadvand, Hassan
Rosmarinic acid prevents post-operative abdominal adhesions in a rat model
title Rosmarinic acid prevents post-operative abdominal adhesions in a rat model
title_full Rosmarinic acid prevents post-operative abdominal adhesions in a rat model
title_fullStr Rosmarinic acid prevents post-operative abdominal adhesions in a rat model
title_full_unstemmed Rosmarinic acid prevents post-operative abdominal adhesions in a rat model
title_short Rosmarinic acid prevents post-operative abdominal adhesions in a rat model
title_sort rosmarinic acid prevents post-operative abdominal adhesions in a rat model
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9633689/
https://www.ncbi.nlm.nih.gov/pubmed/36329196
http://dx.doi.org/10.1038/s41598-022-22000-x
work_keys_str_mv AT kakanezhadiali rosmarinicacidpreventspostoperativeabdominaladhesionsinaratmodel
AT rezaeimehrdad rosmarinicacidpreventspostoperativeabdominaladhesionsinaratmodel
AT raisiabbas rosmarinicacidpreventspostoperativeabdominaladhesionsinaratmodel
AT dezfoulianomid rosmarinicacidpreventspostoperativeabdominaladhesionsinaratmodel
AT davoodifarshid rosmarinicacidpreventspostoperativeabdominaladhesionsinaratmodel
AT ahmadvandhassan rosmarinicacidpreventspostoperativeabdominaladhesionsinaratmodel